Upadacitinib shows promise in treatment-resistant UC and Crohn’sJune 16, 2023IBD & Intestinal Disorders
Pediatric Crohn’s disease: Adalimumab plus methotrexate offers strong benefitJune 13, 2023IBD & Intestinal Disorders
Distal fecal washes reveal inflammation across ileac-colonic axisJune 6, 2023IBD & Intestinal Disorders
New guideline weighs medication options for chronic constipationJune 2, 2023IBD & Intestinal Disorders
Multiple successive biologic to biosimilar switches deemed safe and effectiveMay 31, 2023Mixed TopicsIBD & Intestinal Disorders
Fewer discontinuations with infliximab vs. vedolizumab for UC maintenance therapyMay 12, 2023IBD & Intestinal Disorders
Gut microbiome may guide personalized heart failure therapyApril 28, 2023Mixed TopicsIBD & Intestinal Disorders
FMT in a pill: FDA approves second product to prevent C. diff recurrenceApril 28, 2023IBD & Intestinal Disorders
